News

News

Hikma provides update on generic Advair Diskus® launch

News

News

Hikma Pharmaceuticals and Sesen Bio announce exclusive partnership to commercialise Vicineum™ in MENA

News

News

Hikma launches Icosapent Ethyl Capsules

Our impact

The impact we have on people’s lives is important, positive and far-reaching. Watch this short video to learn about how we supported the treatment of refugees suffering from sickle cell anemia in Lebanon through our donation of critical medicines.

#OwnYour Career @Hikma

#OwnYour Career @Hikma

Our Analytical Research Manager, Rita tells us about her job and what excites her the most about her role​.

Case study

Case study

Our support and impact; improving patient’s access to ritonavir

Insight

Insight

Kept out of reach - tackling the enduring challenge of access to medicine

Update

Update

Hikma update regarding COVID-19

Find out more

Who we are. We make high quality medicines and make them accessible to the people that need them.

News

News

Hikma continues strong 2020 performance and updates full year guidance

Find out more

Find out more

Our commitment to sustainability

Find out more

Find out more

We develop, manufacture and market nearly 700 quality branded and non-branded generic medicines worldwide.